1-anilino-8-naphthalenesulfonate has been researched along with Transfusion Reaction in 1 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Transfusion Reaction: Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nightingale, SL | 1 |
1 other study available for 1-anilino-8-naphthalenesulfonate and Transfusion Reaction
| Article | Year |
|---|---|
From the Food and Drug Administration.
Topics: Anti-Obesity Agents; Blood Transfusion; Drug Approval; Equipment Failure; Humans; Hypotension; Lacto | 1999 |